A new PET-CT scanner has been launched at Norfolk and Norwich University Hospital, to boost access to advanced cancer diagnostics in the East of England.The hospital has advanced its onsite PET-CT service, thanks to…
Continue Reading
Elekta, a global leader in brachytherapy solutions, has acquired iCAD, Inc.’s Xoft business, including the innovative Xoft Axxent Electronic Brachytherapy (eBx) System. This technology, utilizing a miniaturized X-ray source, offers precise cancer treatment with…
Continue Reading
Elekta has won a tender to supply several Harmony linear accelerators (linacs) to Ukraine, aiming to alleviate the country’s cancer treatment shortage. These modern radiation therapy devices will be operational by 2024, enhancing cancer…
Continue Reading
Teri Thomas, CEO and Managing Director at Volpara Health
Breast cancer awareness is essential for early detection, which is critical for improving survival rates and reducing the burden of this disease. October is Breast Cancer…
Continue Reading
Cleveland Clinic and IBM have secured $40 million in funding from the Wellcome Trust to lead quantum computing projects for healthcare applications. The initiative, part of the Wellcome Leap Quantum for Bio Challenge, aims…
Continue Reading
What You Should Know:
– Georgiamune, a privately held, clinical stage biotechnology company, and Verily, an Alphabet precision health technology company forms a strategic partnership to advance novel therapeutics for patients with cancer.
– Through this…
Continue Reading
WHO grade II and III gliomas demonstrate diverse biological behaviors resulting in variable survival outcomes. In the context of glioma prognosis, machine learning (ML) approaches could facilitate the navigation through the maze of factors…
Continue Reading
What You Should Know:
– Cedar Gate Technologies’ advanced AI analytics platform has identified that 55% of commercially insured women are unlikely to get a mammogram. Leveraging this proprietary AI, Cedar Gate evaluated nearly 2.4 million women in its national healthcare benchmark database.
– The model surfaces a probability score for…
Continue Reading
What You Should Know:
Flatiron Health today announced a new agreement to bring Flatiron Assist™ advanced cancer care insights to oncology care clinicians at Penn Medicine’s Abramson Cancer Center (ACC).The collaboration between Flatiron Health and Penn Medicine will…
Continue Reading
What You Should Know: Pangea Biomed, the startup behind the innovative treatment response predictor, ENLIGHT, today announced its partnership with patient-centric advocacy organization FibroFighters to advance treatment for fibrolamellar carcinoma (FLC) patients.Fibrolamellar carcinoma (FLC)…
Continue Reading
